Haya Taitel
Fortune : 356 614 $ au 31/07/2026
Fortune : 356 614 $ au 31/07/2026
Haya Taitel currently works at Entera Bio Ltd., as Independent Director from 2023.
Dr. Taitel also formerly worked at Kadmon Holdings, Inc., as Chief Commercial Officer from 2018 to 2021.
Dr. Taitel received her undergraduate degree from The Hebrew University of Jerusalem and graduate degree from Temple University School of Pharmacy.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENTERA BIO LTD. 0,07% | 07/08/2026 | 119 269 ( 0,07% ) | 356 614 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENTERA BIO LTD. | Directeur/Membre du Conseil | 07/06/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Corporate Officer/Principal | 01/11/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entera Bio Ltd.
Entera Bio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures flu medicines | Health Technology |
Temple University School of Pharmacy
Temple University School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national